May 2026 officially marks a historic turning point in Bepharco's development strategy: The first official sea-freight export shipment has successfully departed for the Myanmar market.

Behind this proud achievement lies a journey of over 700 days of relentless effort. Overcoming stringent barriers and local market fluctuations, the Bepharco team steadfastly adhered to and fully met the regulatory standards of the Myanmar pharmaceutical authority to officially obtain the Marketing Authorizations (Product Visas) and Import Licenses. Today's accomplishment is a powerful testament to the professional capacity, adaptability, and determination of our entire team to conquer international markets.

Representing Bepharco's pharmaceutical quality in this historic maiden shipment to Myanmar are two flagship product lines: Becolugel-S and Becolugel-O. This strategic selection stems from a profound understanding of the local market's specific characteristics.

Every internationally standardized package venturing out to sea today is the crystallization of a methodical planning process: from comprehensive market research and perfecting the legal framework to establishing strategic partnerships and ensuring the most rigorous quality standards. This serves as a clear demonstration of Bepharco's increasingly solid competitive edge within the regional supply chain.

Myanmar is not merely a destination, but a launchpad for a more macroscopic vision. From this strategic milestone, Bepharco will continue its roadmap to expand its presence across Southeast Asia and other key markets. We are step-by-step realizing the aspiration of elevating Vietnamese pharmaceuticals on the global map, remaining steadfast to our core philosophy: “Delivering Integrity – Building Global Trust".